" Approval for a Phase II study of RECCE® 327 as a topical antiinfective therapy for Diabetic Foot Infections"
Good news
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3622 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 4986 | 2 |
View Market Depth
| Last trade - 09.19am 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |
Day chart unavailable